| Literature DB >> 23688927 |
Abstract
Until very recently addiction-research was limited by existing tools and strategies that were inadequate for studying the inherent complexity at each of the different phenomenological levels. However, powerful new tools (e.g., optogenetics and designer drug receptors) and high throughput protocols are starting to give researchers the potential to systematically interrogate "all" genes, epigenetic marks, and neuronal circuits. These advances, combined with imaging technologies (both for preclinical and clinical studies) and a paradigm shift toward open access have spurred an unlimited growth of datasets transforming the way we investigate the neurobiology of substance use disorders (SUD) and the factors that modulate risk and resilience. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'. Published by Elsevier Ltd.Entities:
Keywords: Addiction; Brain imaging; Dopamine; Nucleus accumbens; Reward; SUD
Mesh:
Year: 2013 PMID: 23688927 PMCID: PMC3818510 DOI: 10.1016/j.neuropharm.2013.05.007
Source DB: PubMed Journal: Neuropharmacology ISSN: 0028-3908 Impact factor: 5.250